NeoTX
Immuno-oncology Drug Development
StartupNeoTX is a Rehovot-based startup in the Health Tech & Life Sciences sector, established in 2015. Immuno-oncology Drug Development. The company has raised a total of $65.5M across 4 funding rounds, currently at the C stage. Key investors include J. Tomilson Hil, Maurice Greenberg, NFDOS, among 5 total investors. The company has 11-50 employees. Core technologies: Biologicals, Cells.
With $65.5M in total funding, NeoTX is a C-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Clinical Trial. The company holds 1 patent.
- StageC
- ProductClinical Trial
- ModelB2B
- Employees11-50
- HQRehovot
- DistrictCenter District
- Last Round$45M
- J. Tomilson Hil
- Maurice Greenberg
- NFDOS
5 investors total
10 articles covered by sources including www.geektime.com,
www.prnewswire.com,
www.globenewswire.com,
www.calcalistech.com.
What does NeoTX do?
NeoTX is leveraging its proprietary Selective T cell Redirection (STR) platform to develop new targeted anticancer immunotherapies. STR binds a genetically engineered bacterial determinant to the tumor surface while simultaneously activating immune cells away from the suppressive tumor environment to mount an effective antibacterial response. The technology effectively converts a weak immune response against the tumor to a powerful yet safe native antibacterial immune reaction. The company's lead STR molecule, Naptumomab estafenatox, is currently in clinical development for advanced solid tumors.
How much funding has NeoTX raised?
NeoTX has raised $65.5M in total funding across 4 rounds. The company is currently at the C stage. Key investors include J. Tomilson Hil, Maurice Greenberg, NFDOS.
What sector is NeoTX in?
NeoTX operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals, Cells. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.
Where is NeoTX located?
NeoTX is based in Prof. Haim Pekeris Street 2, Rehovot, Israel, Center District.